← Eichor
Study identifier: NCT02568878 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Creatine for Depressed Male and Female Methamphetamine Users

Condition: Depression · Anxiety · Methamphetamine Dependence  ·  Sponsor: Montana State University

PhasePhase 3
Planned participants29
Who can joinAll sexes, 18 Years to 59 Years
Healthy volunteersNo

About this study

* Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression

This description comes directly from the study's public registry record.

Talk to the study team

Tracy Hellem, PhD  ·  406 243 2110  ·  tracy.hellem1@montana.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Montana State University College of Nursing (Missoula campus)Missoula, Montana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02568878